OptiNose, Inc. Total Assets 2016-2024 | OPTN

OptiNose, Inc. total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
OptiNose, Inc. Annual Total Assets
(Millions of US $)
2023 $108
2022 $144
2021 $166
2020 $189
2019 $173
2018 $217
2017 $241
2016 $42
2015 $0
OptiNose, Inc. Quarterly Total Assets
(Millions of US $)
2024-09-30 $131
2024-06-30 $132
2024-03-31 $84
2023-12-31 $108
2023-09-30 $101
2023-06-30 $106
2023-03-31 $115
2022-12-31 $144
2022-09-30 $105
2022-06-30 $123
2022-03-31 $134
2021-12-31 $166
2021-09-30 $132
2021-06-30 $140
2021-03-31 $158
2020-12-31 $189
2020-09-30 $181
2020-06-30 $153
2020-03-31 $174
2019-12-31 $173
2019-09-30 $149
2019-06-30 $167
2019-03-31 $193
2018-12-31 $217
2018-09-30 $238
2018-06-30 $260
2018-03-31 $221
2017-12-31 $241
2017-09-30 $55
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2015-12-31 $0
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.058B $0.071B
OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) JP $83.888B 33.10
Zoetis Inc. (ZTS) US $71.853B 27.10
Takeda Pharmaceutical Co. (TAK) JP $44.737B 9.90
Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) JP $43.224B 26.34
Sandoz Group AG Sponsored ADR (SDZNY) CH $20.442B 0.00
Merck KGaA (MKKGY) DE $18.230B 16.33
Astellas Pharma Inc. (ALPMY) JP $17.608B 12.47
Summit Therapeutics PLC (SMMT) US $16.312B 0.00
United Therapeutics Corporation (UTHR) US $16.121B 15.86
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) JP $12.709B 0.00
Neurocrine Biosciences, Inc. (NBIX) US $12.033B 36.68
Orion OYJ Unsponsored ADR (ORINY) FI $7.681B 21.59
Madrigal Pharmaceuticals, Inc. (MDGL) US $7.333B 0.00
Corcept Therapeutics Incorporated (CORT) US $6.657B 50.43
Stevanato Group S.p.A. (STVN) IT $6.329B 40.98
Hikma Pharmaceuticals Plc (HKMPF) GB $6.245B 0.00
Ionis Pharmaceuticals, Inc. (IONS) US $5.138B 0.00
Grifols, S.A. (GRFS) ES $5.122B 0.00
Ono Pharmaceutical Co. (OPHLF) JP $4.650B 9.52
Recursion Pharmaceuticals, Inc. (RXRX) US $3.626B 0.00
Crinetics Pharmaceuticals, Inc. (CRNX) US $3.474B 0.00
Catalyst Pharmaceuticals, Inc. (CPRX) US $2.579B 11.69
AMNEAL PHARMACEUTICALS, INC. (AMRX) US $2.426B 14.50
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) GB $2.193B 0.00
Hypermarcas (HYPMY) BR $2.154B 0.00
Soleno Therapeutics, Inc. (SLNO) US $1.989B 0.00
BioCryst Pharmaceuticals, Inc. (BCRX) US $1.908B 0.00
NewAmsterdam Pharma Company N.V. (NAMS) NL $1.716B 0.00
Evotec AG (EVO) DE $1.573B 0.00
Dyne Therapeutics, Inc. (DYN) US $1.426B 0.00
Guardian Pharmacy Services, Inc. (GRDN) US $1.239B 0.00
Ardelyx, Inc. (ARDX) US $1.198B 0.00
Indivior PLC (INDV) US $1.165B 5.06
Aurinia Pharmaceuticals Inc (AUPH) CA $1.135B 0.00
Xencor, Inc. (XNCR) US $1.102B 0.00
Ocular Therapeutix, Inc. (OCUL) US $1.101B 0.00
ARS Pharmaceuticals, Inc. (SPRY) US $1.092B 0.00
Enliven Therapeutics, Inc. (ELVN) US $1.065B 0.00
Harrow, Inc. (HROW) US $1.031B 0.00
Collegium Pharmaceutical, Inc. (COLL) US $0.939B 5.13
Bioventus Inc. (BVS) US $0.812B 25.67
Avadel Pharmaceuticals PLC. (AVDL) IE $0.810B 0.00
Cronos Group Inc. (CRON) CA $0.754B 0.00
Relay Therapeutics, Inc. (RLAY) US $0.656B 0.00
Verve Therapeutics, Inc. (VERV) US $0.616B 0.00
USANA Health Sciences, Inc. (USNA) US $0.606B 11.23
Xeris Biopharma Holdings, Inc. (XERS) US $0.559B 0.00
Elite Pharmaceuticals Inc. (ELTP) US $0.521B 0.00
OmniAb, Inc. (OABI) US $0.515B 0.00
KalVista Pharmaceuticals, Inc. (KALV) US $0.496B 0.00
Savara Inc. (SVRA) US $0.462B 0.00
Theravance Biopharma, Inc. (TBPH) KY $0.458B 0.00
Altimmune, Inc. (ALT) US $0.457B 0.00
ProKidney Corp. (PROK) US $0.437B 0.00
Siga Technologies Inc. (SIGA) US $0.422B 4.92
Zevra Therapeutics, Inc. (ZVRA) US $0.410B 0.00
Organogenesis (ORGO) US $0.404B 0.00
Aldeyra Therapeutics, Inc. (ALDX) US $0.398B 0.00
Akebia Therapeutics, Inc. (AKBA) US $0.393B 0.00
Oruka Therapeutics, Inc. (ORKA) US $0.386B 0.00
CytoDyn Inc. (CYDY) US $0.368B 0.00
Esperion Therapeutics, Inc. (ESPR) US $0.359B 0.00
Rigel Pharmaceuticals, Inc. (RIGL) US $0.354B 143.50
Tourmaline Bio, Inc. (TRML) US $0.313B 0.00
Ironwood Pharmaceuticals, Inc. (IRWD) US $0.290B 0.00
Aquestive Therapeutics, Inc. (AQST) US $0.274B 0.00
Heron Therapeutics, Inc. (HRTX) US $0.263B 0.00
Avita Medical Inc. (RCEL) US $0.256B 0.00
Nature's Sunshine Products, Inc. (NATR) US $0.252B 14.98
Korro Bio, Inc. (KRRO) US $0.246B 0.00
Innate Pharma SA (IPHYF) FR $0.243B 0.00
Amylyx Pharmaceuticals, Inc. (AMLX) US $0.226B 0.00
Profound Medical (PROF) CA $0.225B 0.00
4D Molecular Therapeutics, Inc. (FDMT) US $0.215B 0.00
Inhibikase Therapeutics, Inc. (IKT) US $0.206B 0.00
Lyell Immunopharma, Inc. (LYEL) US $0.205B 0.00
Larimar Therapeutics, Inc. (LRMR) US $0.204B 0.00
MediWound Ltd. (MDWD) IL $0.191B 0.00
Nanobiotix S.A. Sponsored ADR (NBTX) FR $0.177B 0.00
Acrivon Therapeutics, Inc. (ACRV) US $0.172B 0.00
Nektar Therapeutics (NKTR) US $0.172B 0.00
Enanta Pharmaceuticals, Inc. (ENTA) US $0.171B 0.00
VAXART, INC. (VXRT) US $0.162B 0.00
Aclaris Therapeutics, Inc. (ACRS) US $0.160B 0.00
Silence Therapeutics PLC Sponsored ADR (SLN) GB $0.143B 0.00
Champions Oncology, Inc. (CSBR) US $0.141B 0.00
Inotiv, Inc. (NOTV) US $0.137B 0.00
Lexeo Therapeutics, Inc. (LXEO) US $0.129B 0.00
Procaps Group, S.A. (PROCF) LU $0.126B 0.00
Cassava Sciences, Inc. (SAVA) US $0.123B 0.00
electroCore, Inc. (ECOR) US $0.118B 0.00
Telomir Pharmaceuticals, Inc. (TELO) US $0.116B 0.00
Achieve Life Sciences, Inc. (ACHV) CA $0.109B 0.00
Journey Medical Corporation (DERM) US $0.108B 0.00
Corbus Pharmaceuticals Holdings, Inc. (CRBP) US $0.100B 0.00
Cardiol Therapeutics Inc. (CRDL) CA $0.099B 0.00
Galectin Therapeutics Inc. (GALT) US $0.094B 0.00
Arch Biopartners Inc. (ACHFF) CA $0.089B 0.00
Metagenomi, Inc. (MGX) US $0.088B 0.00
Avalo Therapeutics, Inc. (AVTX) US $0.088B 0.00
Regulus Therapeutics Inc. (RGLS) US $0.086B 0.00
Nutriband Inc. (NTRB) US $0.083B 0.00
Assertio Holdings, Inc. (ASRT) US $0.078B 20.32
Protara Therapeutics, Inc. (TARA) US $0.077B 0.00
ESSA Pharma Inc. (EPIX) CA $0.076B 0.00
Pyxis Oncology, Inc. (PYXS) US $0.076B 0.00
Karyopharm Therapeutics Inc. (KPTI) US $0.076B 0.00
Cumberland Pharmaceuticals Inc. (CPIX) US $0.075B 0.00
PMV Pharmaceuticals, Inc. (PMVP) US $0.073B 0.00
FibroGen, Inc (FGEN) US $0.071B 0.00
Mural Oncology PLC (MURA) IE $0.069B 0.00
Fractyl Health, Inc. (GUTS) US $0.068B 0.00
Vivani Medical, Inc. (VANI) US $0.068B 0.00
Unicycive Therapeutics, Inc. (UNCY) US $0.064B 0.00
Century Therapeutics, Inc. (IPSC) US $0.062B 0.00
AleAnna Inc. (ANNA) US $0.062B 0.00
Context Therapeutics Inc. (CNTX) US $0.061B 0.00
Gain Therapeutics, Inc. (GANX) US $0.060B 0.00
Reviva Pharmaceuticals Holdings, Inc. (RVPH) US $0.053B 0.00
Dominari Holdings Inc. (DOMH) US $0.052B 0.00
Iterum Therapeutics PLC (ITRM) IE $0.052B 0.00
Rafael Holdings, Inc. (RFL) US $0.050B 0.00
AlloVir, Inc. (ALVR) US $0.049B 0.00
Prelude Therapeutics Incorporated (PRLD) US $0.048B 0.00
SCYNEXIS, Inc. (SCYX) US $0.041B 0.00
VYNE Therapeutics Inc. (VYNE) US $0.040B 0.00
NRx Pharmaceuticals, Inc. (NRXP) US $0.039B 0.00
CASI Pharmaceuticals Inc. (CASI) CN $0.038B 0.00
Tempest Therapeutics, Inc. (TPST) US $0.038B 0.00
Surrozen, Inc. (SRZN) US $0.036B 0.00
Verrica Pharmaceuticals Inc. (VRCA) US $0.034B 0.00
PolyPid Ltd. (PYPD) IL $0.030B 0.00
Incannex Healthcare Inc. (IXHL) AU $0.029B 0.00
Jupiter Neurosciences, Inc. (JUNS) US $0.028B 0.00
BioVie Inc. (BIVI) US $0.027B 0.00
Natural Alternatives International, Inc. (NAII) US $0.025B 0.00
DURECT Corporation (DRRX) US $0.025B 0.00
Scienture Holdings, Inc. (SCNX) US $0.024B 0.00
Enlivex Therapeutics Ltd. (ENLV) IL $0.021B 0.00
Mannatech, Incorporated (MTEX) US $0.021B 0.00
GlycoMimetics, Inc. (GLYC) US $0.019B 0.00
Carisma Therapeutics Inc. (CARM) US $0.019B 0.00
Vivos Therapeutics, Inc. (VVOS) US $0.018B 0.00
Lipocine Inc. (LPCN) US $0.018B 0.00
MEI Pharma, Inc. (MEIP) US $0.017B 0.00
Tonix Pharmaceuticals Holding Corp. (TNXP) US $0.017B 0.00
MARKER THERAPEUTICS, INC. (MRKR) US $0.017B 0.00
Traws Pharma, Inc. (TRAW) US $0.016B 0.00
Citius Pharmaceuticals, Inc. (CTXR) US $0.015B 0.00
Biomerica, Inc. (BMRA) US $0.015B 0.00
TherapeuticsMD, Inc. (TXMD) US $0.015B 0.00
Cosmos Health Inc. (COSM) US $0.014B 0.00
Lyra Therapeutics, Inc. (LYRA) US $0.013B 0.00
ProPhase Labs, Inc. (PRPH) US $0.013B 0.00
Minerva Neurosciences, Inc (NERV) US $0.013B 0.00
Nuvilex Inc. (PMCB) US $0.012B 0.00
BioLineRx Ltd. (BLRX) IL $0.012B 0.00
Phio Pharmaceuticals Corp. (PHIO) US $0.012B 0.00
Indaptus Therapeutics, Inc. (INDP) US $0.011B 0.00
Mangoceuticals, Inc. (MGRX) US $0.011B 0.00
Kiora Pharmaceuticals, Inc. (KPRX) US $0.010B 0.00
Klotho Neurosciences, Inc. (KLTO) US $0.010B 0.00
Talphera, Inc. (TLPH) US $0.010B 0.00
Jaguar Animal Health, Inc. (JAGX) US $0.010B 0.00
Relmada Therapeutics, Inc. (RLMD) US $0.009B 0.00
Ainos, Inc. (AIMD) US $0.009B 0.00
Addex Therapeutics Ltd. Sponsored ADR (ADXN) CH $0.008B 0.00
XTL Biopharmaceuticals Ltd. (XTLB) IL $0.008B 0.00
Plus Therapeutics, Inc. (PSTV) US $0.007B 0.00
NLS Pharmaceutics Ltd. (NLSP) CH $0.007B 0.00
Xenetic Biosciences, Inc. (XBIO) US $0.006B 0.00
Redhill Biopharma Ltd. (RDHL) IL $0.006B 0.00
Aptorum Group Limited (APM) GB $0.006B 0.00
TransCode Therapeutics Inc. (RNAZ) US $0.006B 0.00
Clearmind Medicine Inc. (CMND) CA $0.006B 0.00
CERo Therapeutics Holdings, Inc. (CERO) US $0.005B 0.00
SciSparc Ltd. (SPRC) IL $0.005B 0.00
Conduit Pharmaceuticals Inc. (CDT) US $0.004B 0.00
Sonoma Pharmaceuticals, Inc. (SNOA) US $0.004B 0.00
InMed Pharmaceuticals Inc. (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals Inc. (SXTP) US $0.003B 0.00
XORTX Therapeutics Inc. (XRTX) CA $0.003B 0.00
Avenue Therapeutics, Inc. (ATXI) US $0.003B 0.07
Alaunos Therapeutics, Inc. (TCRT) US $0.003B 0.00
Qualigen Therapeutics, Inc. (QLGN) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) US $0.003B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals, Inc. (SLRX) US $0.002B 0.00
Galmed Pharmaceuticals Ltd. (GLMD) IL $0.002B 0.00
Heatwurx Inc. (PCSA) US $0.002B 0.00
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) US $0.002B 0.00
Petros Pharmaceuticals, Inc. (PTPI) US $0.001B 0.00
China SXT Pharmaceuticals, Inc. (SXTC) CN $0.001B 0.00
TNF Pharmaceuticals, Inc. (TNFA) US $0.001B 0.00
Aditxt Inc. (ADTX) US $0.001B 0.00
PainReform Ltd. (PRFX) IL $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D pharma PLC Sponsored ADR (LBPS) GB $0.000B 0.00
Patheon N.V. (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals PLC (RVLP) US $0.000B 0.00